Report Detail

Table of Contents

    Global Mebendazole Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 ≥98% -Product Introduction and Major Manufacturers
        • 1.1.2 ≥99% -Product Introduction and Major Manufacturers
        • 1.1.3 Other -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Global Mebendazole Market Assessment, by Segmentation

      • 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
      • 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
      • 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)

      3 Regional Market Analysis

      • 3.1 China Mebendazole Market
        • 3.1.1 Top Companies leading Mebendazole Development in China (2015-2020)
        • 3.1.2 Sales Value of Major Company in China Market (2015-2020)
        • 3.1.3 China Mebendazole Price (USD/Unit), by Type (2019-2020)
        • 3.1.4 Sales in China Market, by Type (2015-2026)
      • 3.2 EU Mebendazole Market
        • 3.2.1 Top Companies leading Mebendazole Development in EU (2015-2020)
        • 3.2.2 Sales Value of Major Company in EU Market (2015-2020)
        • 3.2.3 EU Mebendazole Price (USD/Unit), by Type (2019-2020)
        • 3.2.4 Sales in EU Market, by Type (2015-2026)
      • 3.3 USA Mebendazole Market
        • 3.3.1 Top Companies leading Mebendazole Development in USA (2015-2020)
        • 3.3.2 Sales Value of Major Company in USA Market (2015-2020)
        • 3.3.3 USA Mebendazole Price (USD/Unit), by Type (2019-2020)
        • 3.3.4 Sales in USA Market, by Type (2015-2026)
      • 3.4 Japan Mebendazole Market
        • 3.4.1 Top Companies leading Mebendazole Development in Japan (2015-2020)
        • 3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
        • 3.4.3 Japan Mebendazole Price (USD/Unit), by Type (2019-2020)
        • 3.4.4 Sales in Japan Market, by Type (2015-2026)
      • 3.5 India Mebendazole Market
        • 3.5.1 Top Companies leading Mebendazole Development in India (2015-2020)
        • 3.5.2 Sales Value of Major Company in India Market (2015-2020)
        • 3.5.3 India Mebendazole Price (USD/Unit), by Type (2019-2020)
        • 3.5.4 Sales in India Market, by Type (2015-2026)
      • 3.6 Southeast Asia Mebendazole Market
        • 3.6.1 Top Companies leading Mebendazole Development in Southeast Asia (2015-2020)
        • 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
        • 3.6.3 Southeast Asia Mebendazole Price (USD/Unit), by Type (2019-2020)
        • 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
      • 3.7 South America Mebendazole Market
        • 3.7.1 Top Companies leading Mebendazole Development in South America (2015-2020)
        • 3.7.2 Sales Value of Major Company in South America Market (2015-2020)
        • 3.7.3 South America Mebendazole Price (USD/Unit), by Type (2019-2020)
        • 3.7.4 Sales in South America Market, by Type (2015-2026)

      4 Value Chain (Impact of COVID-19)

      • 4.1 Mebendazole Value Chain Analysis
        • 4.1.1 Upstream
        • 4.1.2 Downstream
      • 4.2 COVID-19 Impact on Mebendazole Industry
        • 4.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 4.3 Cost-Under the Epidemic Situation
        • 4.3.1 Cost of Raw Material
      • 4.4 Channel Analysis
        • 4.4.1 Distribution Channel-Under the Epidemic Situation
        • 4.4.2 Distributors

      5 Regional Market Forecast (2021-2026)

      • 5.1 Global Mebendazole Sales and Growth Rate (2021-2026)
      • 5.2 Global Mebendazole Sales Value and Growth Rate (2021-2026)

      6 Mebendazole Competitive Analysis

      • 6.1 Changzhou Yabang-QH Pharmachem
        • 6.1.1 Changzhou Yabang-QH Pharmachem Company Profiles
        • 6.1.2 Changzhou Yabang-QH Pharmachem Product Introduction
        • 6.1.3 Changzhou Yabang-QH Pharmachem Mebendazole Production, Revenue (2015-2020)
        • 6.1.4 SWOT Analysis
      • 6.2 Aarambh Life Science
        • 6.2.1 Aarambh Life Science Company Profiles
        • 6.2.2 Aarambh Life Science Product Introduction
        • 6.2.3 Aarambh Life Science Mebendazole Production, Revenue (2015-2020)
        • 6.2.4 SWOT Analysis
      • 6.3 Neha Pharma Private Limited
        • 6.3.1 Neha Pharma Private Limited Company Profiles
        • 6.3.2 Neha Pharma Private Limited Product Introduction
        • 6.3.3 Neha Pharma Private Limited Mebendazole Production, Revenue (2015-2020)
        • 6.3.4 SWOT Analysis
      • 6.4 Adani Pharmachem Private Limited
        • 6.4.1 Adani Pharmachem Private Limited Company Profiles
        • 6.4.2 Adani Pharmachem Private Limited Product Introduction
        • 6.4.3 Adani Pharmachem Private Limited Mebendazole Production, Revenue (2015-2020)
        • 6.4.4 SWOT Analysis
      • 6.5 Shanghai Ziqi Biotechnology
        • 6.5.1 Shanghai Ziqi Biotechnology Company Profiles
        • 6.5.2 Shanghai Ziqi Biotechnology Product Introduction
        • 6.5.3 Shanghai Ziqi Biotechnology Mebendazole Production, Revenue (2015-2020)
        • 6.5.4 SWOT Analysis
      • 6.6 Xi'an Janssen Pharmaceutical
        • 6.6.1 Xi'an Janssen Pharmaceutical Company Profiles
        • 6.6.2 Xi'an Janssen Pharmaceutical Product Introduction
        • 6.6.3 Xi'an Janssen Pharmaceutical Mebendazole Production, Revenue (2015-2020)
        • 6.6.4 SWOT Analysis
      • 6.7 Shaanxi Hanjiang Pharmaceutical Group
        • 6.7.1 Shaanxi Hanjiang Pharmaceutical Group Company Profiles
        • 6.7.2 Shaanxi Hanjiang Pharmaceutical Group Product Introduction
        • 6.7.3 Shaanxi Hanjiang Pharmaceutical Group Mebendazole Production, Revenue (2015-2020)
        • 6.7.4 SWOT Analysis
      • 6.8 Hubei Widely Chemical Technology
        • 6.8.1 Hubei Widely Chemical Technology Company Profiles
        • 6.8.2 Hubei Widely Chemical Technology Product Introduction
        • 6.8.3 Hubei Widely Chemical Technology Mebendazole Production, Revenue (2015-2020)
        • 6.8.4 SWOT Analysis
      • 6.9 AdvaCare
        • 6.9.1 AdvaCare Company Profiles
        • 6.9.2 AdvaCare Product Introduction
        • 6.9.3 AdvaCare Mebendazole Production, Revenue (2015-2020)
        • 6.9.4 SWOT Analysis
      • 6.10 Cadila Pharmaceuticals
        • 6.10.1 Cadila Pharmaceuticals Company Profiles
        • 6.10.2 Cadila Pharmaceuticals Product Introduction
        • 6.10.3 Cadila Pharmaceuticals Mebendazole Production, Revenue (2015-2020)
        • 6.10.4 SWOT Analysis

      7 Conclusion

      Summary

      As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

      Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
      In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
      Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
      Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Mebendazole market in this environment.

      In terms of revenue, this research report indicated that the global Mebendazole market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Mebendazole industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

      The Changzhou Yabang-QH Pharmachem aims at producing XX Mebendazole in 2020, with XX % production to take place in global market, Aarambh Life Science accounts for a volume share of XX %.

      Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Mebendazole Market by XYZResearch Include
      China
      EU
      USA
      Japan
      India
      Southeast Asia
      South America
      Competitive Analysis; Who are the Major Players in Mebendazole Market?
      Changzhou Yabang-QH Pharmachem
      Aarambh Life Science
      Neha Pharma Private Limited
      Adani Pharmachem Private Limited
      Shanghai Ziqi Biotechnology
      Xi'an Janssen Pharmaceutical
      Shaanxi Hanjiang Pharmaceutical Group
      Hubei Widely Chemical Technology
      AdvaCare
      Cadila Pharmaceuticals
      ...
      Major Type of Mebendazole Covered in XYZResearch report:
      ≥98%
      ≥99%
      Other
      Application Segments Covered in XYZResearch Market
      Feed Additives
      Tablet
      Oral Suspension

      For any other requirements, please feel free to contact us and we will provide you customized report.


      Summary:
      Get latest Market Research Reports on Mebendazole. Industry analysis & Market Report on Mebendazole is a syndicated market report, published as Post-pandemic Era-Global Mebendazole Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026. It is complete Research Study and Industry Analysis of Mebendazole market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,650.00
      $5,600.00
      2,642.60
      4,054.40
      3,124.40
      4,793.60
      417,231.50
      640,136.00
      273,494.50
      419,608.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report